• Economic and Environmental Geology
• /
• v.48 no.3
• /
• pp.199-204
• /
• 2015

In this study, we aimed to make antibiotic-intercalated smectite composites using amoxicillin and clarithromycin as hygroscopic antibiotics, and gentamicin, tobramycin and netilmicin as non-hygroscopic aminoglucosides, and to check their drug delivery potential in gastric system using preliminary in-situ column release test for clarithromycinsmectite composite. All antibiotics were successfully intercalated into the interlayer of smectite by cation-exchange reaction in the batch experiment. Equilibrium batch test showed that clarithromycin-intercalation followed Langmuir isotherm and the possible maximum amount was calculated as 1.811 mmole/g. Clarithromycin was continuously released by the solutions of pH=2, 3, and 4 and the amount was decreased with pH increase.

• Journal of fish pathology
• /
• v.23 no.2
• /
• pp.221-227
• /
• 2010

Effects of temperature ($13{\pm}1.5^{\circ}C$, $23{\pm}1.5^{\circ}C$) on the pharmacokinetic properties of oxolinic acid (OA) were studied after oral administration to cultured black rockfish, Sebastes schlegeli. Serum concentrations of OA were determined using HPLC-UV detector after a single dosage of 60 mg/kg body weight (average about 500 g). The peak serum concentrations of OA at $23{\pm}1.5^{\circ}C$ and $13{\pm}1.5^{\circ}C$ were $0.60{\mu}/ml$ at 30 h and $2.22{\mu}g/ml$ at 10 h post-dose, respectively. Better absorption of OA was noted at $13{\pm}1.5^{\circ}C$ compared to $23{\pm}1.5^{\circ}C$. The elimination of OA from serum was considerably faster at $23{\pm}1.5^{\circ}C$ than at $13{\pm}1.5^{\circ}C$. Both absorption and elimination of OA were affected significantly by temperature. The kinetic profile of absorption, distribution and elimination of OA in serum was analyzed by fitting to a two compartment model, with WinNonlin program. The AUC, Tmax and Cmax at $23{\pm}1.5^{\circ}C$ were $42.16{\mu}g{\cdot}h/m\ell$, 26.13 h and $0.43{\mu}g/ml$, respectively. The AUC, Tmax and Cmax at $13{\pm}1.5^{\circ}C$ were $131.98{\mu}g{\cdot}h/ml$, 8.81 h and $2.04{\mu}g/ml$, respectively.

• Korean Journal of Veterinary Research
• /
• v.35 no.4
• /
• pp.683-689
• /
• 1995

임상적으로 건강한 New Zealand White 종인 수컷 토끼에서 항생제 norfloxacin(NFX)의 체내 동태를 조사하기 위하여 체중 kg당 5mg을 정맥 및 경구 투여하였다. 그 결과 빠른 분포기와 소실기를 갖는 2-콤파트먼트 모델 양상으로 나타났다. 혈장에서의 약물분석은 HPLC로 실시하였는데, 이동상은 acetonitrile/0.01M phosphate buffer/ 10% citric acid 1mM heptane sulfonic acid(10/70/20)이었고, 흡수 파장은 274nm에서 실시하였다. 정맥 투여후, 생물학적 반감기는 3.14시간으로 나타났으며, 분포반감기는 0.38시간으로 빠른 분포를 보여주었다. 최고 혈중농도는 $24.27{\mu}g/ml$로 계산되었으며 청소율은 0.68ml/kg/h로 분석되었다. 경구 투여후, 최고 혈중 농도와 최고 혈중 도달 시간은 $0.86{\mu}g/ml$과 0.43시간으로 각각 계산되었다. 이때의 생물학적 반감기는 3.61시간으로 정맥 투여시와 유의성 있는 차이는 없었으며, 흡수 반감기는 0.17시간으로 빠른 흡수를 보여주었다. 생체이용율은 30%로 나타났으며, 0.2-1.6g/ml인 치료혈중 농도 범위에서 혈장 결합율은 26%로 나타나, 토끼에서 항생요법은 구강 투여시 초기 투여량은 2.71mg/kg이며, 유지 투여량은 12시간마다 2.54mg/kg이 적당한 것으로 분석되었다.

• The KIPS Transactions:PartB
• /
• v.11B no.3
• /
• pp.281-288
• /
• 2004

In order to extract and analyze complex features of the behavior of animals in response to external stimuli such as toxic chemicals, we implemented an adaptive computational method to characterize changes in the behavior of chironomids in response to treatment with the insecticide, diazinon. In this paper, we propose an energy minimization model to extract the features of response behavior of chironomids under toxic treatment, which is applied on the image of velocity vectors. It is based on the improved active contour model and the variations of the energy functional, which are produced by the evolving active contour. The movement tracks of individual chironomid larvae were continuously measured in 0.25 second intervals during the survey period of 4 days before and after the treatment. Velocity on each sample track at 0.25 second intervals was collected in 15-20 minute periods and was subsequently checked to effectively reveal behavioral states of the specimens tested. Active contour was formed around each collection of velocities to gradually evolve to find the optimal boundaries of velocity collections through processes of energy minimization. The active contour which is improved by T. Chan and L. Vese is used in this paper. The energy minimization model effectively revealed characteristic patterns of behavior for the treatment versus no treatment, and identified changes in behavioral states .is the time progressed.

• Korean Journal of Clinical Pharmacy
• /
• v.17 no.1
• /
• pp.13-18
• /
• 2007

The purpose of the present study was to investigate the effect of cimetidine on theophylline pharmacokinetics in Korean healthy normal subjects. Eight subjects were enrolled and open label, two period cross-over study was conducted without significant drug related adverse reactions. Cimetidine seemed that significantly inhibited the metabolism of theophylline, oral clearance decreased significantly when cimetidine was coadministered. Coadministered cimetidine increased $AUC_t$ and $C_{max}$ of theophylline. All subjects were genotyped using PCR-RFLP methods to evaluate the differences in metabolic capacity in accordance with CYP1A2 genotypes, but no mutant genotype was found. This suggests that metabolic capacities were not significantly affected by CYP1A2 genotypes among subjects. In conclusion, disposition of theophylline was significantly affected by coadministered cimetidine. Further evaluation with well-designed drug interaction study in accordance with various genotype of CYP1A2 is needed.

• Journal of fish pathology
• /
• v.22 no.1
• /
• pp.91-95
• /
• 2009

The pharmacokinetic properties of oxytetracycline (OTC) were studied after intramuscular injection to cultured olive flounder, Paralichthys olivaceus. Plasma concentrations of OTC were determined after dosage of 12.5, 25 and 50 ㎎/㎏ body weight in olive flounder (average 600 g, $23{\pm}1{^{\circ}C}$). Plasma samples were taken at 3, 5, 10, 15, 24, 32, 48, 72, 120, 168, 240 and 360 h post-dose. With 25 and 50 ㎎/㎏, the peak plasma concentrations of OTC, which attained at 5 h post-dose, were 0.99 and 1.49 $\mu{g}/m\ell$, respectively. However, the peak plasma concentration of 12.5 ㎎/㎏ was 0.35 $\mu{g}/m\ell$ after 10 h post-dose. Plasma concentrations of OTC were not measurable at 360 h post-dose in all doses. The kinetic profile of absorption, distribution and elimination of OTC in plasma were analyzed fitting to a 1-compartment model by Win-Nonlin program. The following parameters were calculated for 12.5, 25 and 50 ㎎/㎏ body weight, respectively: AUC (the area under the concentration-time curve)?D���D24.98, 44.67 and 50.45 $\mu{g}$ $h/m\ell$ $T_{1/2}$ (half-life) ?D���D0.42, 0.59 and 0.41 h; $T_{max}$ (time for maximum concentration)?D���D8.46, 6.34 and 2.66 h; $C_{max}$ (maximum concentration)?D���D0.30, 0.63 and 1.13 $\mu{g}/m\ell$.

• Proceeding of EDISON Challenge
• /
• 2017.03a
• /
• pp.151-157
• /
• 2017

암으로 인해 사망하는 인류를 위해 많은 연구자들이 노력하고 있다. 하지만 아직까지도 암세포를 선택적으로 파괴하여 완치하는 것은 힘든 일이다. 우리는 암세포에만 특이적으로 작용하는 항암제를 연구하고자 계획하였고, 암세포에만 선택적으로 약물 분자를 전달하는 캡슐을 만들기 위해서 컴퓨터를 이용한 계산화학 기법을 사용하기로 하였다. 3차원 캡슐은 고려할 변수가 너무 많기 때문에 2차원 캡슐을 모델링하여 어떤 조건에서 캡슐이 열리고 닫히는지 확인하였다. 고리의 길이와 고리 말단끼리 서로 끌어당기는 힘이 캡슐이 열리고 닫히는지 주요한 요인으로 작용하였고 이 결과를 통해 실제 항암제로의 적용가능성을 시뮬레이션을 통해 확인할 수 있었다.

• Proceedings of the Korea Information Processing Society Conference
• /
• 2010.11a
• /
• pp.1739-1742
• /
• 2010

IT 기술과 바이오 기술의 융합을 통해 경제적, 기술적 측면에서 효과적인 연구 및 개발을 위한 노력들이 증가하고 있다. 이를 위해서는 계산 집약적인 다양한 응용 프로그램들이 서로 유기적으로 통합되어 결과를 도출하도록 관리할 수 있어야 한다. 본 논문에서는 인체 생리기능 단위들을 모사한 신약개발 시뮬레이션을 지원하는 OSICC (e-Organ Simulator-Integrated Cyber Computing) 시스템을 위한 워크플로우 관리자를 제안한다. 제안하는 시스템은 복잡한 약물독성 시뮬레이션을 위해 워크플로우를 이용해 시뮬레이션의 구성과 조합을 효율화하였으며, 프로토타입으로 구현되어 효율적인 시뮬레이션 환경 제공이 가능함을 확인하였다.

• Journal of the Korea Convergence Society
• /
• v.11 no.10
• /
• pp.349-353
• /
• 2020

Background: The dosage of the anesthetic drugs is generally determined by the total body weight of the patients. However, the drugs can be overdosed when the patient is morbidly obese. We have determined anesthetic induction dose based on lean body mass estimated from bioelectrical impedance analysis (BIA). Case: We report a case of morbidly obese patient (161 cm, 138 kg and body mass index 53.1) who had an elective laparoscopic cholecystectomy. The dose of induction agent was determined by lean body mass estimated by BIA, and the sedation was assessed by the observer's assessment alertness/sedation scale. Conclusions: Dose determination through lean body mass measured by BIA is useful in highly obese patients.

• Journal of the Korea Convergence Society
• /
• v.13 no.1
• /
• pp.101-107
• /
• 2022

Tertomotide is a peptide vaccine developed for anti-cancer therapy. Since it has been found to ameliorate inflammatory symptoms in animal studies and clinical test, we investigated anti-inflammation activity of the tertomotide and the mechanism of action in monocyte in order to assess if tertomotide may serve as an anti-inflammatory agent by checking inflammatory cytokines and related signaling pathway following tertomotide treatment. We found that tertomotide reduced the level of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-8 in LPS- or PMA-stimulated monocyte cell line and suppressed NF-κB signaling including the activation of ERK1/2 and P38 MAPK following TNF-α treatment. These results may correlate to the beneficial findings in animal studies, implicating that tertomotide may act as a potential anti-inflammatory agent. This study is an exemplary case for convergence that a computationally designed peptide for immunological purpose exerting unexpected biological activity may elicit novel anti-inflammatory drug.